Tableted COVID-19 Therapeutic Vaccine
Clinical trial NCT04380532 · UNKNOWN
Trial details
- NCT number
- NCT04380532
- Sponsor
- Immunitor LLC
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2021-05-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.